Comparative Effectiveness of Roctavian to Standard of Care

Study identification

• EU PAS number:
  EUPAS1000001075
• Study ID:
  1000001075
• Official title and acronym:
  Comparative Effectiveness of Roctavian to Standard of Care
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  Comparative Effectiveness of Roctavian to Standard of Care Hemostatic Therapies in Germany Among People with Severe Hemophilia A: A Prospective Non-Interventional Study Utilizing Data Collected in the German Hemophilia Register.
• Study status:
  Discontinued

Research institutions and networks

Institutions

IQVIA

United Kingdom

Study timelines

Date when funding contract was signed

Planned:01/10/2024

Actual:01/01/2025

Study start date

Planned:09/01/2025

Actual:09/01/2025

Data analysis start date

Actual:07/09/2025

Date of final study report

Planned:08/06/2026

Actual:08/06/2026

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

No information provided.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable